000			01742nam a2200469 i 4500
999			_c277986 _d277986
001			on1078638765
003			OCoLC
005			20190117104431.0
006			m o d f
007			cr mn|||||||||
008			181210s2016 pauab ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dMvI
042			_apcc
043			_an-us-de
074			_a0967-L-03 (online)
086	0		_aJ 24.34:D 37
099			_aJ 24.34:D 37
245	0	4	_aThe drug situation in Delaware.
264		1	_a[Philadelphia, Pa.] : _bDEA Philadelphia Field Division, _c2016.
300			_a1 online resource (20 pages) : _bcolor illustrations, color map.
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
490	1		_a"DEA intelligence report
500			_a"This product was prepared by the DEA Philadelphia Field Division"--Page 20.
500			_a"Unclassified."
500			_a"May 2016."
500			_aDEA-PHL-DIR-046-16."
500			_aCRDP Program record.
504			_aIncludes bibliographical references (pages 19-20).
588			_aDescription based on online resource, PDF version; title from cover (DEA website, viewed December 10, 2018).
710	1		_aUnited States. _bDrug Enforcement Administration. _bPhiladelphia Division,
830		0	_aDEA intelligence report.
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo112755
650		0	_aDrug accessibility _zDelaware _vStatistics.
650		0	_aDrugs _xOverdose _zDelaware _vStatistics.
650		0	_aDeath _xCauses _vStatistics.
650		0	_aNaloxone _zDelaware _vStatistics.
650		0	_aDrug monitoring _zDelaware _vStatistics.
650		0	_aDrug abuse _xTreatment _zDelaware _vStatistics.
942			_2sudocs _c8